Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 24.00
+0.80 (3.45%)
At close: Jun 2, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 136.85 million as of June 2, 2026. Its market cap has increased by 19.17% in one year.
Market Cap
136.85M
Enterprise Value
282.21M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
24.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 136.85M, a decrease of -43.09%. That is a compound annual growth rate of -12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 136.85M | -3.93% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.44B |
| Idorsia | 1.12B |
| Basilea Pharmaceutica AG | 645.82M |
| Newron Pharmaceuticals | 272.60M |
| Santhera Pharmaceuticals Holding AG | 220.37M |
| BioVersys AG | 157.90M |
| Molecular Partners AG | 117.47M |
| MindMaze Therapeutics Holding | 57.53M |